Sign in
Taking people in United StatesNo phase

Removing Surrogates Uncertainty to Reduce Fear and Anxiety After Cardiac Events - Kids

Key facts

Who runs it
Children's Hospital of Philadelphia
Where
Philadelphia, United StatesSee the site
Trial code
Status
Recruiting
People taking part
30 people, planned
Started
1 Jun 2026
Expected to end
31 May 2027
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Education Intervention
Record updated
16 July 2026

Who can take part

Age
0 days to 17 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Caregiver
  • Caregiver of a child <17.5 years of age who had at least a 2 minute cardiac arrest, is expected to be discharged within 30 days, and to survive at least 3 months post-discharge from hospital
  • English speaking; Child
  • <17.5 years of age
  • Have had a cardiac arrest lasting more than 2 minutes within the past 7 days and have not yet been discharged from pediatric intensive care unit (PICU) or cardiac intensive care unit (CICU)

Who cannot take part

  • Parent or legal guardian is not the child's caregiver

This trial is currently available in United States.

  • Children's Hospital of PhiladelphiaPhiladelphia, United StatesContact: Elizabeth Herrup, MDTaking people

About the trial

What the trial wants to find out

This pilot randomized controlled trial (RCT) will test the feasibility and acceptability of the informational intervention program, Heartsight, to reduce caregivers' uncertainty experienced throughout their child's illness trajectory after cardiac arrest. The investigator aims to enroll up to 30 caregivers of pediatric cardiac arrest patients to (Aim 1a) pilot recruitment and randomization (2:1) procedures, and (Aim 1b) estimate retention rate at 3 months and assess engagement and utilization metrics for frequency of access and time spent on each module of the informational packages. The investigator also aims to evaluate the association of the intervention with efficacy outcomes in an exploratory manner in preparation for a larger trial, including (Aim2a) a preliminary estimate of the association of intervention with the surrogate's uncertainty levels at 3 months post-discharge, and (Aim 2b) a preliminary estimate of the association of intervention with the surrogate's anxiety, depression, and post-traumatic stress symptoms at 3 months post-discharge.

The 2 groups in the trial

  • InterventionOther group

    Caregivers will receive cardiac arrest education intervention called Heartsight

    Treatment: Education Intervention

  • Usual CareNo study treatment, for comparison

    Patients and caregivers will receive usual care

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
16 July 2026